MustGrow News Releases

Saskatoon, SK, November 15, 2019 – MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (the "Company", "MustGrow"), an agricultural biotech company developing and commercializing a portfolio of natural, science-based bio-pesticides, is pleased to announce a non-brokered private placement (the "Private Placement") of approximately 4,285,714 units (each a "Unit") for gross proceeds of up to approximately C$1,500,000 at a price per Unit of C$0.35.

Each Unit shall consist of one common share of the Company and one-half of one common share purchase warrant (each a "Warrant"). Each full Warrant shall entitle the holder to acquire one common share of the Company at a price of C$0.50 for a period of 24 months following the closing of the Private Placement.

  • National state of emergency declared in Colombia.
  • New soil-borne Fusarium pathogen is threatening the global supply of bananas.
  • Effective eradication is currently not possible, with Fusarium wilt TR4 remaining viable for decades in the soil.
  • MustGrow independent studies have confirmed 100% control of a similar soil-borne resilient Fusarium pathogen.

  • Mustard-derived formulation improves efficacy and economics through concentration of the active ingredient in a liquid format.
  • Efficacy Results: 100% control of hard-to-kill soil borne diseases such as Botrytis and Fusarium.
  • Economic Feasibility: >95% control achieved at rates as low as 2.5 gal/acre, resulting in a potentially economically-feasible application rate for fruits, vegetables, turf, ornamental, cannabis and hemp farming operations.
  • More farmers are seeking ‘natural biological’ alternatives to ‘chemistry-based’ products, some of which are dangerous to human health.